Tezepelumab COPD Exacerbation Study

PHASE2CompletedINTERVENTIONAL
Enrollment

337

Participants

Timeline

Start Date

July 30, 2019

Primary Completion Date

November 10, 2023

Study Completion Date

January 31, 2024

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
BIOLOGICAL

Tezepelumab

Tezepelumab subcutaneous injection

OTHER

Placebo

Placebo subcutaneous injection

Trial Locations (91)

2400

Research Site, København NV

2650

Research Site, Hvidovre

4000

Research Site, Roskilde

5000

Research Site, Odense C

7100

Research Site, Vejle

8200

Research Site, Aarhus N

9000

Research Site, Aalborg

11765

Research Site, Uijeongbu-si

12203

Research Site, Berlin

13015

Research Site, Marseille

15213

Research Site, Pittsburgh

18014

Research Site, Granada

19140

Research Site, Philadelphia

20927

Research Site, Großhansdorf

21431

Research Site, Incheon

23552

Research Site, Lübeck

24210

Research Site, Abingdon

28117

Research Site, Mooresville

28277

Research Site, Charlotte

28562

Research Site, New Bern

29010

Research Site, Málaga

29464

Research Site, Mt. Pleasant

29609

Research Site, Brest

29732

Research Site, Rock Hill

32405

Research Site, Panama City

32819

Research Site, Orlando

33511

Research Site, Brandon

33607

Research Site, Tampa

34090

Research Site, Montpellier

34362

Research Site, Haifa

36305

Research Site, Dothan

38043

Research Site, Grenoble

42415

Research Site, Daegu

43215

Research Site, Columbus

44093

Research Site, Nantes

46410

Research Site, Alzira

49281

Research Site, Kfar Saba

49620

Research Site, Buckley

54907

Research Site, Jeonju

55131

Research Site, Mainz

57702

Research Site, Rapid City

60596

Research Site, Frankfurt

69317

Research Site, Lyon

73034

Research Site, Edmond

75069

Research Site, McKinney

80054

Research Site, Amiens

84101

Research Site, Beersheba

87108

Research Site, Albuquerque

91031

Research Site, Jerusalem

91120

Research Site, Jerusalem

91786

Research Site, Upland

92647

Research Site, Huntington Beach

92663

Research Site, Newport Beach

92683

Research Site, Westminster

97504

Research Site, Medford

98208

Research Site, Everett

7661041

Research Site, Rehovot

7830604

Research Site, Ashkelon

06510

Research Site, New Haven

32789-4681

Research Site, Winter Park

T2N 4Z6

Research Site, Calgary

T8L 0N2

Research Site, Sherwood Park

V5Z 1M9

Research Site, Vancouver

B2N 1L2

Research Site, Truro

L7N 3V2

Research Site, Burlington

L8N 3Z5

Research Site, Hamilton

H1M 1B1

Research Site, Montreal

G1V 4G5

Research Site, Québec

G3K 2P8

Research Site, Québec

J6E 2B4

Research Site, Saint-Charles-Borromée

G8T 7A1

Research Site, Trois-Rivières

5623 EJ

Research Site, Eindhoven

6419 PC

Research Site, Heerlen

3045 PM

Research Site, Rotterdam

3083 AN

Research Site, Rotterdam

7207 AE

Research Site, Zutphen

03312

Research Site, Seoul

03722

Research Site, Seoul

05030

Research Site, Seoul

05505

Research Site, Seoul

06591

Research Site, Seoul

06973

Research Site, Seoul

08025

Research Site, Barcelona

06800

Research Site, Mérida (Badajoz)

BND9 6RJ

Research Site, Bradford

KT16 0PZ

Research Site, Chertsey

HU16 5JQ

Research Site, Cottingham

G12 0YN

Research Site, Glasgow

SW10 9NH

Research Site, London

NE1 4LP

Research Site, Newcastle upon Tyne

WF1 4DG

Research Site, Wakefield

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

AstraZeneca

INDUSTRY